Alpha-synuclein is a protein in the human brain that is linked with the development of Parkinson’s disease - Dr. David K.Simon

 An important scientific paper was published in the journal Science by Mittal et al describing how some common drugs, already approved by the U.S. Food and Drug Administration for other purposes, may lower the production of alpha-synuclein and potentially protect against Parkinson’s. David K. Simon, MD, PhD, Director of the Parkinson's Disease and Movement Disorders Center at Beth Israel Deaconess Medical Center in Boston, describes what the researchers did and what they found.